Stay updated with breaking news from Athersys Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com upgraded shares of Athersys (NASDAQ:ATHX – Get Rating) from a sell rating to a hold rating in a report published on Tuesday. Separately, Alliance Global Partners began coverage on shares of Athersys in a research note on Monday, March 6th. They issued a buy rating and a $5.50 price objective on the stock. Athersys […]
Stock Analysts’ upgrades for Tuesday, May 2nd: Athersys (NASDAQ:ATHX) was upgraded by analysts at StockNews.com from a sell rating to a hold rating. Franklin Resources (NYSE:BEN) was upgraded by analysts at StockNews.com from a sell rating to a hold rating. Conn’s (NASDAQ:CONN) was upgraded by analysts at StockNews.com from a sell rating to a hold […]
Athersys (NASDAQ:ATHX – Get Rating) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in a research note issued on Tuesday. Separately, Alliance Global Partners initiated coverage on Athersys in a report on Monday, March 6th. They set a “buy” rating and a $5.50 target price on the stock. Athersys Trading Down […]
Athersys, Inc. (NASDAQ:ATHX – Get Rating) was the recipient of a significant decrease in short interest during the month of April. As of April 15th, there was short interest totalling 1,130,000 shares, a decrease of 9.6% from the March 31st total of 1,250,000 shares. Based on an average daily volume of 243,600 shares, the days-to-cover […]
Athersys, Inc. , a regenerative medicine company developing MultiStem® cell therapy for critical care indications, announced today their participation in the Cellular Therapeutics in Trauma and... | May 1, 2023